1. Home
  2. NRXP vs CULP Comparison

NRXP vs CULP Comparison

Compare NRXP & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CULP
  • Stock Information
  • Founded
  • NRXP 2015
  • CULP 1972
  • Country
  • NRXP United States
  • CULP United States
  • Employees
  • NRXP N/A
  • CULP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • NRXP Health Care
  • CULP Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • CULP Nasdaq
  • Market Cap
  • NRXP 58.5M
  • CULP 54.5M
  • IPO Year
  • NRXP N/A
  • CULP N/A
  • Fundamental
  • Price
  • NRXP $2.84
  • CULP $4.33
  • Analyst Decision
  • NRXP Strong Buy
  • CULP
  • Analyst Count
  • NRXP 5
  • CULP 0
  • Target Price
  • NRXP $31.40
  • CULP N/A
  • AVG Volume (30 Days)
  • NRXP 562.9K
  • CULP 12.2K
  • Earning Date
  • NRXP 08-18-2025
  • CULP 09-10-2025
  • Dividend Yield
  • NRXP N/A
  • CULP N/A
  • EPS Growth
  • NRXP N/A
  • CULP N/A
  • EPS
  • NRXP N/A
  • CULP N/A
  • Revenue
  • NRXP N/A
  • CULP $213,237,000.00
  • Revenue This Year
  • NRXP N/A
  • CULP $2.41
  • Revenue Next Year
  • NRXP $231.16
  • CULP $3.46
  • P/E Ratio
  • NRXP N/A
  • CULP N/A
  • Revenue Growth
  • NRXP N/A
  • CULP N/A
  • 52 Week Low
  • NRXP $1.10
  • CULP $3.42
  • 52 Week High
  • NRXP $6.01
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 56.21
  • CULP 54.27
  • Support Level
  • NRXP $2.26
  • CULP $4.08
  • Resistance Level
  • NRXP $2.81
  • CULP $4.39
  • Average True Range (ATR)
  • NRXP 0.23
  • CULP 0.13
  • MACD
  • NRXP 0.04
  • CULP 0.02
  • Stochastic Oscillator
  • NRXP 78.38
  • CULP 85.95

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: